Five things for pharma marketers to know: Wednesday, September 27, 2017

Share this content:

1. AbbVie said comments made by CEO Richard Gonzalez were “incorrectly characterized.” Media outlets reported that Gonzalez told analysts that public anger at the high prices of drugs is waning and that he didn't expect any changes in regulation. (Politico)

2. Pandora is the latest technology company making a play for pharma ad dollars. At least 20 drugmakers are advertising with the music-streaming service. (Stat)

3. The devastation in Puerto Rico in the wake of Hurricane Maria may lead to shortages of certain drugs manufactured there. However, the makers of cholesterol drug Crestor, arthritis drug Humira, and HIV drug Prezist said supplies of those drugs have not been affected. (USA Today)

4. Many women are unaware of the risks associated with taking an epilepsy drug while pregnant, researchers said. (Reuters)

5. Alvogen's U.S. business is reportedly up for sale. Its owners, including CVS Capital Partners, are exploring options. (Bloomberg)

Share this content:
Scroll down to see the next article